| 2022-08-01 | +123.4% | news | Seeking Alpha | Monkeypox test marketer Virax rallies 120% after NYC declares public health emergency |
| 2022-08-01 | +123.4% | news | Benzinga | Why Is Virax Biolabs Stock Soaring Today? - Virax Biolabs Group (NASDAQ:VRAX) - Benzinga |
| 2024-06-06 | +84.2% | news | Seeking Alpha | Virax surges amid bird flu concerns |
| 2024-06-06 | +84.2% | news | TradingView | VRAX Stock Price and Chart — NASDAQ:VRAX - TradingView |
| 2024-08-19 | +66.3% | news | Seeking Alpha | Mpox test makers end day with huge gains as disease spreads |
| 2024-08-19 | +66.3% | news | Seeking Alpha | Mpox stocks are on the move as outbreak spreads globally |
| 2025-12-03 | +63.4% | news | PR Newswire | Virax Biolabs Group Limited Announces $5 Million Private Placement - PR Newswire |
| 2025-12-03 | +63.4% | executive | PR Newswire | Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - PR Newswire |
| 2025-12-03 | +63.4% | news | Investing.com | Virax Biolabs stock rockets after clinical progress in post-infection diagnostics - Investing.com |
| 2025-12-03 | +63.4% | news | TipRanks | Why Is Virax Biolabs (VRAX) Stock Rocketing Higher Today? - TipRanks |
| 2025-12-03 | +63.4% | earnings | Benzinga | US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Black Diamond Therapeutic (NASDAQ:BDTX), Capricor Th - Benzinga |
| 2023-03-07 | +62.8% | news | Seeking Alpha | Virax Biolabs stock rockets 107% after introducing Avian Influenza A Virus PCR test kit |
| 2026-04-12 | +58.6% | analyst | MSN | Virax Biolabs Group (VRAX) price target decreased by 95.00% to 1.02 - MSN |
| 2024-12-17 | +57.3% | executive | PR Newswire | Virax Biolabs' CEO James Foster Issues Letter to Shareholders - PR Newswire |
| 2026-04-13 | +40.1% | news | Associated Press | BC-Most Active Stocks |
| 2026-04-13 | +40.1% | news | Benzinga | 12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga |
| 2026-04-13 | +40.1% | news | Benzinga | 12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga |
| 2026-04-13 | +40.1% | earnings | Benzinga | Dow Dips Over 350 Points; Goldman Sachs Posts Upbeat Earnings - Benzinga |
| 2026-04-09 | -31.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | What are hedge funds doing with Virax (VRAX) Stock | VRAX Market Analysis - Macro Risk - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2022-11-04 | -29.0% | news | Seeking Alpha | Virax Biolabs to sell 2.3M shares for ~$3.8M |
| 2023-04-19 | -28.2% | news | Seeking Alpha | Virax stock surges ~30% on distribution pact for Marburg Virus test kits |
| 2022-09-20 | +25.9% | expansion | Seeking Alpha | Virax stock soars 40% on launch of monkeypox rapid test kits |
| 2024-08-20 | +24.1% | news | Seeking Alpha | Mpox Stocks Have Popped, But Pickings Are Slim For The Discerning Investor |
| 2026-04-10 | +22.1% | news | Stock Titan | Warrant exercises lift Virax Biolabs (VRAX) to 19.9M shares outstanding - Stock Titan |
| 2026-04-10 | +22.1% | news | TipRanks | Virax Biolabs Announces Full Exercise of Pre-Funded Warrants From $5 Million Private Placement - TipRanks |
| 2026-04-10 | +22.1% | news | Benzinga | 12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga |
| 2023-03-08 | -21.5% | news | Seeking Alpha | Virax Biolabs to raise $4M in stock offering |
| 2025-07-18 | +20.5% | news | Seeking Alpha | Virax Biolabs receives Nasdaq letter over non-compliance with minimum bid price rule |
| 2026-04-06 | -20.1% | news | Benzinga | 12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga |
| 2026-03-31 | +17.8% | news | Benzinga | What's Behind The Jump In Virax Biolabs Stock? - Benzinga |
| 2026-03-31 | +17.8% | news | Stock Titan | Virax adds medical-device quality standards as U.S. studies advance - Stock Titan |
| 2026-03-31 | +17.8% | news | Stock Titan | Director Nelson Haight reports Virax Biolabs (VRAX) stock option awards - Stock Titan |
| 2026-03-31 | +17.8% | news | Investing.com | Virax Biolabs subsidiary receives ISO quality certifications - Investing.com |
| 2022-11-08 | -16.9% | news | ChartMill | VRAX Stock Price, Quote & Chart | VIRAX BIOLABS GROUP LTD (NASDAQ:VRAX) - ChartMill |
| 2024-04-02 | +16.2% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-08-22 | -15.1% | news | Seeking Alpha | Virax Biolabs looks to raise $5M via stock offering |
| 2022-08-17 | -12.4% | news | TradingView | Virax Biolabs Group Limited Financial Statements – NASDAQ:VRAX - TradingView |
| 2024-09-16 | +10.6% | expansion | Seeking Alpha | Virax Biolabs extends distribution agreement to market Mpox detection kits |
| 2023-02-07 | +10.3% | expansion | Seeking Alpha | Virax stock rises on contract with Cosmos to market COVID, Influenza combo rapid test |
| 2022-07-26 | +9.9% | expansion | Seeking Alpha | Virax Biolabs stock falls 15% amid launch of real-time PCR test for monkeypox in Europe |
| 2024-09-05 | -9.4% | news | Seeking Alpha | Singapore announces quarantine measures for close contacts of mpox infected patients |
| 2023-12-06 | -9.4% | legal | Seeking Alpha | Virax Biolabs files for up to $30M mixed securities shelf |
| 2026-03-18 | -8.7% | executive | Stock Titan | Virax Biolabs (VRAX) CEO reports holdings in shares and options - Stock Titan |
| 2026-03-18 | -8.7% | news | Stock Titan | Virax Biolabs (VRAX) backs reverse split range and 2M-share incentive plan - Stock Titan |
| 2026-03-18 | -8.7% | news | TipRanks | Virax Biolabs Shareholders Approve Reverse Split, New Charter and 2026 Equity Plan After Adjourned AGM - TipRanks |
| 2025-12-04 | -8.7% | news | PR Newswire | Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement - PR Newswire |
| 2026-01-15 | -8.3% | analyst | Yahoo Finance | Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Yahoo Finance |
| 2026-01-15 | -8.3% | news | Zacks Investment Research | Should I buy Virax Biolabs Group Limited (VRAX) - Zacks Investment Research |
| 2026-04-14 | -8.0% | executive | PR Newswire | Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders |
| 2026-04-14 | -8.0% | executive | PR Newswire | Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders - PR Newswire |
| 2026-04-14 | -8.0% | news | Stock Titan | Virax Biolabs (NASDAQ: VRAX) maps ViraxImmune PAIS plan and notes cash-rich valuation gap - Stock Titan |
| 2026-04-14 | -8.0% | news | Benzinga | 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga |
| 2026-04-14 | -8.0% | news | Benzinga | 12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga |
| 2026-01-09 | -7.9% | news | Intellectia AI | VRAX Should I Buy - Intellectia AI |
| 2022-12-06 | -7.9% | news | Seeking Alpha | COVID-19 rapid antigen test distributed by Virax Biolabs receives emergency use authorization |
| 2025-03-05 | -6.8% | news | Stock Titan | Can Virax's T-Cell Research at WIRM 2025 Advance Post-Infection Syndrome Treatment? - Stock Titan |
| 2022-10-26 | +6.6% | news | Seeking Alpha | Virax to start trial of COVID-19 cytometry kit for immune risk profiling |
| 2022-09-13 | -6.2% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Virax Biolabs Group Limited (VRAX) - Zacks Investment Research |
| 2025-01-13 | -5.7% | expansion | Seeking Alpha | Cosmos Health announces distribution agreement with Virax Biolabs |
| 2024-08-29 | -5.3% | news | Stock Titan | Virax Biolabs to Participate at 7th European Congress of Immunology - Stock Titan |
| 2022-09-22 | -5.2% | M&A | Seeking Alpha | Virax Biolabs jumps 19% on distribution deal for monkeypox tests |
| 2026-01-30 | -4.8% | legal | Stock Titan | VRAX SEC Filings - Virax Biolabs Group Ltd 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2024-08-28 | +4.0% | M&A | Seeking Alpha | Virax stock rallies 22% on mpox detection kit deal |
| 2023-08-03 | +3.7% | news | Seeking Alpha | Virax Biolabs receives extension to regain Nasdaq compliance |
| 2023-09-01 | +3.6% | executive | Seeking Alpha | Virax Biolabs appoints Nigel McCracken as Chief Operating Officer |
| 2025-08-27 | -3.4% | news | Yahoo Finance | Virax Biolabs (VRAX) Falls 18% on Lack of Leads - Yahoo Finance |
| 2025-02-27 | -3.4% | news | Seeking Alpha | WHO maintains public health emergency alert on mpox |
| 2026-03-23 | +2.2% | news | Stock Titan | If You Invested $1,000 in Virax Biolabs Group Ltd (VRAX) - Stock Titan |
| 2022-11-03 | -1.6% | expansion | Seeking Alpha | Virax stock soars 23% on launch of RSV-Influenza-COVID combo rapid test |
| 2022-11-03 | -1.6% | news | Kalkine Media | Virax Biolabs (VRAX) stock pops over 40% at market open; Here's why - Kalkine Media |
| 2026-03-25 | -1.6% | news | Benzinga | 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga |
| 2023-12-14 | +1.5% | news | Seeking Alpha | Virax Biolabs announces 1-for-10 share consolidation |
| 2023-12-14 | +1.5% | news | PR Newswire | Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation - PR Newswire |
| 2023-03-30 | -1.3% | news | CoinCodex | Virax Biolabs Group Limited (VRAX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2025-06-01 | +1.2% | news | Intellectia AI | VRAX Forecast — Price Prediction for 2026. Should I Buy VRAX? - Intellectia AI |
| 2024-03-15 | -0.8% | news | Seeking Alpha | Virax Biolabs receives Nasdaq notification letter regarding minimum bid price deficiency |
| 2025-02-25 | +0.4% | news | Stock Titan | How Virax's Vaccine Testing Tech Could Capitalize on New Government Transparency Push - Stock Titan |
| 2023-10-24 | -0.1% | news | ChartMill | VRAX Technical Analysis | Trend, Signals & Chart Patterns | VIRAX BIOLABS GROUP LTD (NASDAQ:VRAX) - ChartMill |
| 2026-04-25 | — | news | Quiver Quantitative | Virax Biolabs Group Limited Or Stock Short Interest Rises to 71.68% - Quiver Quantitative |
| 2022-07-21 | — | news | Seeking Alpha | Virax Biolabs surges 300% in post-IPO debut |